SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-044402
Filing Date
2019-11-25
Accepted
2019-11-25 17:26:34
Documents
14
Period of Report
2019-11-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K CLOSING alks-8k_20191121.htm   iXBRL 8-K 52528
2 EX-2.1 alks-ex21_15.htm EX-2.1 879633
3 EX-99.1 alks-ex991_16.htm EX-99.1 16056
  Complete submission text file 0001564590-19-044402.txt   1228490

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alks-20191121.xsd EX-101.SCH 5968
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20191121_lab.xml EX-101.LAB 19413
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20191121_pre.xml EX-101.PRE 11606
8 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20191121_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 191247107
SIC: 2834 Pharmaceutical Preparations